JP2023543763A5 - - Google Patents
Info
- Publication number
- JP2023543763A5 JP2023543763A5 JP2023518817A JP2023518817A JP2023543763A5 JP 2023543763 A5 JP2023543763 A5 JP 2023543763A5 JP 2023518817 A JP2023518817 A JP 2023518817A JP 2023518817 A JP2023518817 A JP 2023518817A JP 2023543763 A5 JP2023543763 A5 JP 2023543763A5
- Authority
- JP
- Japan
- Prior art keywords
- foxo1
- subject
- nafld
- gene
- hepatocytes
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB2015056.1A GB202015056D0 (en) | 2020-09-23 | 2020-09-23 | Biomarkers |
| GB2015056.1 | 2020-09-23 | ||
| PCT/GB2021/052469 WO2022064198A1 (en) | 2020-09-23 | 2021-09-23 | Biomarkers |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023543763A JP2023543763A (ja) | 2023-10-18 |
| JP2023543763A5 true JP2023543763A5 (enExample) | 2024-09-27 |
Family
ID=73139042
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023518817A Pending JP2023543763A (ja) | 2020-09-23 | 2021-09-23 | バイオマーカー |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US20230348983A1 (enExample) |
| EP (1) | EP4217507A1 (enExample) |
| JP (1) | JP2023543763A (enExample) |
| CN (1) | CN116867910A (enExample) |
| GB (1) | GB202015056D0 (enExample) |
| WO (1) | WO2022064198A1 (enExample) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20250028934A1 (en) * | 2023-07-17 | 2025-01-23 | The Toronto-Dominion Bank | Systems and methods for time series prediction using multi-stage computation |
| US20250263702A1 (en) * | 2024-02-19 | 2025-08-21 | Flagship Pioneering Innovations Vii, Llc | Rnai agents targeting cideb and related methods |
| WO2025230979A1 (en) * | 2024-04-30 | 2025-11-06 | Flagship Pioneering Innovations Vii, Llc | Tnfaip3-targeted compositions and related methods |
| WO2026038054A2 (en) * | 2024-08-15 | 2026-02-19 | Genome Research Limited | Novel companion diagnostic method |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2005009971A1 (ja) | 2003-07-24 | 2005-02-03 | Astellas Pharma Inc. | キノロン誘導体又はその塩 |
| JP2011526482A (ja) * | 2008-07-03 | 2011-10-13 | サンタリス ファーマ アー／エス | ミトコンドリアグリセロール−３−リン酸アシルトランスフェラーゼ１（ｍｔｇｐａｔ１）の発現を阻害するためのｒｎａアンタゴニスト化合物 |
| CN102741426B (zh) * | 2009-09-11 | 2015-03-25 | 香港中文大学 | 用于评估肝病变的方法 |
| JP2018169277A (ja) * | 2017-03-29 | 2018-11-01 | 国立大学法人神戸大学 | 炎症性関連病態を伴う非アルコール性脂肪性肝疾患のバイオマーカー |
| US11808772B2 (en) * | 2017-07-19 | 2023-11-07 | Bio-Rad Europe Gmbh | Biomarker combinations to simultaneously evaluate non-alcoholic steatohepatitis and hepatic fibrosis status |
| IT201800006129A1 (it) * | 2018-06-08 | 2019-12-08 | Uso dello SNP rs17618244 come marcatore predittivo nella NAFLD. | |
| WO2020044497A1 (ja) * | 2018-08-30 | 2020-03-05 | 国立大学法人 東京大学 | Ｎａｆｌｄ又はｎａｓｈの検出又はリスクの予測方法、ｎａｆｌｄ又はｎａｓｈを検出するための診断薬キット、対象における肝線維化の進行度の判定方法、及び対象における肝線維化の進行度を判定するための診断薬キット |
-
2020
- 2020-09-23 GB GBGB2015056.1A patent/GB202015056D0/en not_active Ceased
-
2021
- 2021-09-23 EP EP21782794.8A patent/EP4217507A1/en not_active Withdrawn
- 2021-09-23 US US18/027,874 patent/US20230348983A1/en not_active Abandoned
- 2021-09-23 WO PCT/GB2021/052469 patent/WO2022064198A1/en not_active Ceased
- 2021-09-23 JP JP2023518817A patent/JP2023543763A/ja active Pending
- 2021-09-23 CN CN202180078581.9A patent/CN116867910A/zh active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Graham et al. | Use of cell-SELEX to generate DNA aptamers as molecular probes of HPV-associated cervical cancer cells | |
| US20220218847A1 (en) | Compositions and methods characterizing metastasis | |
| KR102539897B1 (ko) | 직장암의 선행화학방사선 표준 치료 반응 예측 및 치료 후 예후 예측을 위한 조성물 및 표준 치료 후 예후가 매우 나쁜 환자를 예측하는 방법 및 조성물 | |
| CN110791560B (zh) | 一种用于阿尔茨海默病诊断和/或治疗的miRNA标志物 | |
| US20010039016A1 (en) | Use of expression profiling for identifying molecular markers useful for diagnosis of metastatic cancer | |
| JP6745820B2 (ja) | 前立腺がん予後判定の方法 | |
| US12504380B2 (en) | Immunoassays for detection of ran proteins | |
| JP2007126463A (ja) | 様々な癌を診断、監視、段階づけ、造影及び治療する新規な方法 | |
| JP2008520242A5 (enExample) | ||
| CN106414774A (zh) | 胆道癌的检测试剂盒或装置以及检测方法 | |
| JPH09508800A (ja) | 差次的発現遺伝子の同定法 | |
| JP2012521772A (ja) | 癌の診断及び癌処置のモニタリングのための方法 | |
| JP2009544284A5 (enExample) | ||
| JP2008118915A (ja) | 胃癌高発現遺伝子特定による胃癌診断および創薬への利用 | |
| JP2003508022A5 (enExample) | ||
| CN111518884B (zh) | miRNA30簇作为阿尔茨海默病诊断标志物的应用 | |
| KR20080114683A (ko) | 질병에 대한 바이오마커로서의 지방생성 아데노바이러스 | |
| JP2002518051A5 (enExample) | ||
| JP2008512984A5 (enExample) | ||
| CN118389661B (zh) | Ald肝损伤的非侵入性生物标志物及应用 | |
| CN111647670A (zh) | 一种与肾病综合征相关的肠道菌属Faecalitalea及其应用 | |
| KR101997320B1 (ko) | 항암 치료 내성 판단 방법 및 상기 방법에 사용되는 조성물 | |
| WO2011146937A1 (en) | Methods and kits useful in diagnosing nsclc | |
| CN105154533A (zh) | 诊断早期肝癌的miRNA组合及其试剂盒 | |
| JP2007511474A5 (enExample) |